Abstract
One hundred and forty‐eight patients with gastric cancer admitted to Keio University Hospital between July 1988 and October 1992 underwent resection of the primary lesion, as well as single‐cell suspension assay of fresh surgical materials with 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT assay) for chemosensitivity evaluation. Fifty patients with histologically stage III or IV gastric cancer were enrolled in this study, among whom 10 received no chemotherapy after surgery while 40 received chemotherapy at equivalent dose levels after surgery. The patients given chemotherapy were divided into two groups consisting of an “Adapted” group treated with at least one agent identified as effective by the assay, and a “Non‐adapted” group treated with agents to which the cells were not sensitive in the assay, in order to identify the optimal cut‐off inhibition rate (IR) in MTT assay for evaluation of the appropriate adjuvant cancer chemotherapy after surgery. A cut‐off IR of 30% was optimal for differentiating the survival rates between the “Adapted” and “Non‐adapted” groups. Patients treated with drugs which showed more than 30% IR on their surgical specimens showed a better survival rate than patients treated with drugs which were ineffective in the assay.
Keywords: MTT assay, Gastric cancer, Chemosensitivity test
Full Text
The Full Text of this article is available as a PDF (254.6 KB).
REFERENCES
- 1. ) Hamburger , A. W. and Salmon , S. E.Primary bioassay of human tumor stem cells . Science , 197 , 461 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Von Hoff , D. D.He's not giong to talk about in vitro predictive assays again, is he ? J. Natl. Cancer Inst. , 82 , 96 – 101 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Mosmann , T.Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays . J. Immunol. Methods , 65 , 55 – 63 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Shimoyama , Y. , Kubota , T. , Watanabe , M. , Ishibiki , K. and Abe , O.Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay . J. Surg. Oncol. , 41 , 12 – 18 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Suto , A. , Kubota , T. , Shimoyama , Y. , Ishibiki , K. and Abe , O.MTT assay with reference to the clinical effect of chemotherapy . J. Surg. Oncol. , 42 , 28 – 32 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Furukawa , T. , Kubota , T. , Suto , A. , Takahara , T. , Yamaguchi , H. , Takeuchi , T. , Kase , S. , Kodaira , S. , Ishibiki , K. and Kitajima , K.Clinical usefulness of chemosensitivity testing using the MTT assay . J. Surg. Oncol. , 48 , 188 – 193 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Japanese Research Society for Gastric Cancer . “ The General Rules for Gastric Cancer Study. 11th Ed. ” ( 1985. ). Kanehara Shuppan; , Tokyo ( in Japanese ). [Google Scholar]
- 8. ) Kaplan , E. L. and Meier , P.Nonparametric estimation from incomplete observations . J. Am. Stat. Assoc. , 53 , 457 – 481 ( 1958. ). [Google Scholar]
- 9. ) MacDonald , J. S. and Gohmann , J. J.Chemotherapy for advanced gastric cancer. Present status, future prospects . Semin. Oncol. , 15 ( Suppl. 4 ), 42 – 49 ( 1988. ). [PubMed] [Google Scholar]
- 10. ) Von Hoff , D. D. , Clark , G. M. , Stogdill , B. J. , Sarosdy , M. F. , O'Brien , M. T. , Casper , J. T. , Mattox , D. E. , Page , C. P. , Cruz , A. B. and Sandbach , J. F.Prospective clinical trial of a human tumor cloning system . Cancer Res. , 43 , 1926 – 1931 ( 1983. ). [PubMed] [Google Scholar]
- 11. ) Kubota , T. , Kawamura , E. , Kurihara , H. , Ishibiki , K. and Abe , O.Clinical study of clonogenic assay ‐ with reference to adjuvant cancer chemotherapy after operation . J. Jpn. Surg. Sac. , 87 , 154 – 161 ( 1986. ) ( in Japanese ). [PubMed] [Google Scholar]
- 12. ) Alcobendas , F. , Milla , A. , Estape , J. , Curto , J. and Pera , C.Mitomycin C as an adjuvant in resected gastric cancer . Ann. Surg. , 198 , 13 – 17 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. ) Comis , R. L. and Carter , S. K.Integration of chemotherapy into combined modality treatment of solid tumors, III, gastric cancer . Cancer Treat. Rev. , 1 , 221 – 238 ( 1974. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Carter , S. K.Cancer treatment today and its impact on drug development with special emphasis on the phase II clinical trial . J. Natl. Cancer Inst. , 57 , 253 – 344 ( 1976. ). [DOI] [PubMed] [Google Scholar]